>
Switch to:

Travere Therapeutics Net Margin %

: -44.09% (As of Sep. 2020)
View and export this data going back to 2003. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Travere Therapeutics's Net Income for the three months ended in Sep. 2020 was $-22.5 Mil. Travere Therapeutics's Revenue for the three months ended in Sep. 2020 was $51.1 Mil. Therefore, Travere Therapeutics's net margin for the quarter that ended in Sep. 2020 was -44.09%.

NAS:TVTX' s Net Margin % Range Over the Past 10 Years
Min: -393.36   Med: -50.53   Max: 117.36
Current: -40.24

-393.36
117.36

NAS:TVTX's Net Margin % is ranked higher than
65% of the 929 Companies
in the Biotechnology industry.

( Industry Median: -191.41 vs. NAS:TVTX: -40.24 )

Travere Therapeutics Net Margin % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Travere Therapeutics Annual Data
Feb11 Feb12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.36 -35.86 -38.55 -62.51 -83.51

Travere Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.23 -64.81 1.69 -53.83 -44.09

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Travere Therapeutics Net Margin % Distribution

* The bar in red indicates where Travere Therapeutics's Net Margin % falls into.



Travere Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Travere Therapeutics's Net Margin for the fiscal year that ended in Dec. 2019 is calculated as

Net Margin=Net Income (A: Dec. 2019 )/Revenue (A: Dec. 2019 )
=-146.427/175.338
=-83.51 %

Travere Therapeutics's Net Margin for the quarter that ended in Sep. 2020 is calculated as

Net Margin=Net Income (Q: Sep. 2020 )/Revenue (Q: Sep. 2020 )
=-22.549/51.139
=-44.09 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Travere Therapeutics  (NAS:TVTX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Travere Therapeutics Net Margin % Related Terms


Travere Therapeutics Net Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)